General Information of Disease (ID: DISA0XP5)

Disease Name Fungal keratitis
Disease Hierarchy
DISN2KPA: Corneal infection
DIS0X16C: Fungal infection of eye
DISEM33Q: Infectious disease
DISA0XP5: Fungal keratitis
Disease Identifiers
MONDO ID
MONDO_0033821
UMLS CUI
C1262117
MedGen ID
687913
Orphanet ID
519930
SNOMED CT ID
314558005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Natamycin DMFEHXD Approved Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
CD209 TTBXIM9 Strong Genetic Variation [2]
------------------------------------------------------------------------------------
This Disease Is Related to 3 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CLEC4E OT7P8ICY Strong Altered Expression [3]
CLEC7A OTRTBH27 Strong Biomarker [4]
HEYL OTN7BH79 Strong Biomarker [5]
------------------------------------------------------------------------------------

References

1 Natamycin FDA Label
2 Association of Dectin-1 and DC-SIGN gene single nucleotide polymorphisms with fungal keratitis in the northern Han Chinese population.Mol Vis. 2015 Apr 10;21:391-402. eCollection 2015.
3 The role of Mincle in innate immune to fungal keratitis.J Infect Dev Ctries. 2017 Jan 30;11(1):89-97. doi: 10.3855/jidc.7570.
4 Fusarium solani Activates Dectin-1 in Experimentally Induced Keratomycosis.Curr Med Sci. 2018 Feb;38(1):153-159. doi: 10.1007/s11596-018-1859-4. Epub 2018 Mar 15.
5 Cellular morphological changes detected by laser scanning in vivo confocal microscopy associated with clinical outcome in fungal keratitis.Sci Rep. 2019 Jun 6;9(1):8334. doi: 10.1038/s41598-019-44833-9.